Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

EPA:ALISP - Euronext Paris - Matif - ES0109429037 - Common Stock - Currency: EUR

2.08  -0.08 (-3.7%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALISP. ALISP was compared to 62 industry peers in the Media industry. Both the profitability and financial health of ALISP have multiple concerns. ALISP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALISP had negative earnings in the past year.
ALISP had a negative operating cash flow in the past year.
In multiple years ALISP reported negative net income over the last 5 years.
In multiple years ALISP reported negative operating cash flow during the last 5 years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.60%, ALISP is doing worse than 67.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of -9.85%, ALISP is doing worse than 70.97% of the companies in the same industry.
ALISP's Return On Invested Capital of 2.85% is in line compared to the rest of the industry. ALISP outperforms 40.32% of its industry peers.
ALISP had an Average Return On Invested Capital over the past 3 years of 13.74%. This is significantly above the industry average of 8.25%.
The 3 year average ROIC (13.74%) for ALISP is well above the current ROIC(2.85%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROIC 2.85%
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

ALISP has a worse Operating Margin (0.45%) than 70.97% of its industry peers.
ALISP's Operating Margin has declined in the last couple of years.
ALISP's Gross Margin of 31.54% is on the low side compared to the rest of the industry. ALISP is outperformed by 74.19% of its industry peers.
In the last couple of years the Gross Margin of ALISP has declined.
Industry RankSector Rank
OM 0.45%
PM (TTM) N/A
GM 31.54%
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

ALISP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALISP has about the same amout of shares outstanding than it did 1 year ago.
ALISP has more shares outstanding than it did 5 years ago.
ALISP has a worse debt/assets ratio than last year.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.31 indicates that ALISP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.31, ALISP is in the better half of the industry, outperforming 79.03% of the companies in the same industry.
ALISP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.10, ALISP is in line with its industry, outperforming 40.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 2.31
ROIC/WACC0.45
WACC6.4%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.95 indicates that ALISP may have some problems paying its short term obligations.
ALISP has a Current ratio (0.95) which is comparable to the rest of the industry.
ALISP has a Quick Ratio of 0.95. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.95, ALISP perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALISP have decreased strongly by -116.55% in the last year.
The Revenue has grown by 11.47% in the past year. This is quite good.
Measured over the past years, ALISP shows a very strong growth in Revenue. The Revenue has been growing by 43.98% on average per year.
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%

3.2 Future

ALISP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 309.27% yearly.
Based on estimates for the next years, ALISP will show a small growth in Revenue. The Revenue will grow by 4.86% on average per year.
EPS Next Y1075%
EPS Next 2Y309.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALISP. In the last year negative earnings were reported.
ALISP is valuated reasonably with a Price/Forward Earnings ratio of 8.59.
75.81% of the companies in the same industry are more expensive than ALISP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, ALISP is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.59
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALISP indicates a slightly more expensive valuation: ALISP is more expensive than 67.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.64
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALISP's earnings are expected to grow with 309.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y309.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALISP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPD NETWORK

EPA:ALISP (7/1/2025, 7:00:00 PM)

2.08

-0.08 (-3.7%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-24 2024-07-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.97M
Analysts86.67
Price Target5.15 (147.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-12.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.59
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 6.45
P/tB N/A
EV/EBITDA 20.64
EPS(TTM)-0.03
EYN/A
EPS(NY)0.24
Fwd EY11.64%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS10.48
BVpS0.32
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROCE 3.88%
ROIC 2.85%
ROICexc 4.45%
ROICexgc N/A
OM 0.45%
PM (TTM) N/A
GM 31.54%
FCFM N/A
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ROICexc(3y)49.31%
ROICexc(5y)157.45%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.7%
ROCE(5y)19.84%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-80.84%
ROICexc growth 5YN/A
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
F-Score1
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 123.02%
Cap/Sales 0.99%
Interest Coverage 1.02
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 2.31
F-Score1
WACC6.4%
ROIC/WACC0.45
Cap/Depr(3y)110.41%
Cap/Depr(5y)81.37%
Cap/Sales(3y)0.96%
Cap/Sales(5y)0.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
EPS Next Y1075%
EPS Next 2Y309.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%
EBIT growth 1Y-87.83%
EBIT growth 3Y-55.63%
EBIT growth 5YN/A
EBIT Next Year200%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.15%
OCF growth 3YN/A
OCF growth 5YN/A